Literature DB >> 19027714

NGF-induced Tyro3 and Axl function as survival factors for differentiating PC12 cells.

Yan Zheng1, Lijuan Zhang, Qingjun Lu, Xuan Wang, Fen Yu, Xiaomin Wang, Qingxian Lu.   

Abstract

Tyro3 and Axl, two members of the TAM family of receptor tyrosine kinases, play important regulatory roles in a variety of tissues, including the central nervous, reproductive, immune, and vascular systems. We have found that expression of Tyro3 and Axl on PC12 cells is upregulated by nerve growth factor (NGF). PI3K inhibitor LY294002, which is known to inhibit NGF-induced PC12 differentiation, blocked up-regulation of Tyro3 and Axl. NGF regulates Tyro3 and Axl expression by activating their transcription. Both Tyro3 and Axl were associated with the NGF receptor, and protected PC12 cells from stress or toxin-induced cell death. Gas6, a common ligand for both Tyro3 and Axl, was able to replace NGF to support PC12 growth in serum-free medium, and to prevent cell death following serum deprivation. In summary, both Tyro3 and Axl receptors are upregulated by NGF on the differentiating PC12, where they collaborate with TrkA to support neuronal differentiation and survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027714     DOI: 10.1016/j.bbrc.2008.11.049

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.

Authors:  Bridget Shafit-Zagardo; Ross C Gruber; Juwen C DuBois
Journal:  Pharmacol Ther       Date:  2018-03-04       Impact factor: 12.310

2.  Expressions of Axl and Tyro-3 receptors are under regulation of nerve growth factor and are involved in differentiation of PC12 cells.

Authors:  Qi Wang; Qing-Jun Lu; Bing Xiao; Yan Zheng; Xiao-Min Wang
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

3.  Regulation of phagocytosis by TAM receptors and their ligands.

Authors:  Lu Qingxian; Li Qiutang; Lu Qingjun
Journal:  Front Biol (Beijing)       Date:  2010-06

4.  TAM receptors in leukemia: expression, signaling, and therapeutic implications.

Authors:  Luis Brandão; Justine Migdall-Wilson; Kristen Eisenman; Douglas K Graham
Journal:  Crit Rev Oncog       Date:  2011

5.  Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein.

Authors:  Melinda A Brindley; Catherine L Hunt; Andrew S Kondratowicz; Jill Bowman; Patrick L Sinn; Paul B McCray; Kathrina Quinn; Melodie L Weller; John A Chiorini; Wendy Maury
Journal:  Virology       Date:  2011-05-06       Impact factor: 3.616

6.  Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis.

Authors:  Cornelia Blaser; Matthias Wittwer; Denis Grandgirard; Stephen L Leib
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

Review 7.  TAM receptor deficiency affects adult hippocampal neurogenesis.

Authors:  Rui Ji; Lingbin Meng; Qiutang Li; Qingxian Lu
Journal:  Metab Brain Dis       Date:  2014-12-10       Impact factor: 3.584

8.  Transcriptional responses of cultured rat sympathetic neurons during BMP-7-induced dendritic growth.

Authors:  Michelle M Garred; Michael M Wang; Xin Guo; Christina A Harrington; Pamela J Lein
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

9.  Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and β-amyloid deposition in Alzheimer's disease models.

Authors:  Yan Zheng; Qi Wang; Bing Xiao; Qingjun Lu; Yizheng Wang; Xiaomin Wang
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

10.  The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.

Authors:  Hyun-Jung Park; Ji-Yeon Baen; Ye-Ji Lee; Youn-Hee Choi; Jihee Lee Kang
Journal:  Mol Biol Cell       Date:  2012-06-27       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.